Skip Navigation

A Phase III, Randomized Study of Nivolumab Opdivo Plus AVD or Brentuximab Vedotin Adcetris Plus AVD in Patients Age /= 12 Years with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Brief Summary

Type:
Lymphomas

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03907488

Study #:
STUDY00144518

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03907488

View Complete Trial Details & Eligibility at ClinicalTrials.gov